CasLoc logo
All Cases PTAB Litigations UPC Oppositions

OTSUKA PHARMACEUTICAL CO., LTD. v. AMNEAL PHARMACEUTICALS LLC

1:15-cv-01585

Overview

Case Number 1:15-cv-01585
Filing Date 2015-03-02
Status Terminated
Termination Date 2019-07-15
Court District Court, D. New Jersey (njd)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 28:1338 Patent Infringement
Jury Demand None

Parties

Defendant

AMNEAL PHARMACEUTICALS LLC Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

OTSUKA PHARMACEUTICAL CO., LTD. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. New Jersey (njd)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): πŸ‡―πŸ‡΅ Japan πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8759350
Carbostyril derivatives and serotonin reuptake inhibitors for treatment of mood disorders
Filed: 2003-12-25
Issued: 2014-06-24
Active (0.5 yrs remaining) +1256d PTA
Expires: 2027-06-03

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Scrutiny / Risk

High PTA (+1256 days) / In re Cellect scrutiny applies.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Procedural Motions & Interlocutory Orders

Motion Intelligence

Total Motions

61

Dispositive

21

Granted

19

Denied

0

Pending / Review

30

Motions by Category

Procedural / Extension Motion 28 Motion for Preliminary Injunction / TRO 9 Claim Construction / Markman Filing 7 Motion to Strike / Sanctions 5 Motion for Summary Judgment (Infringement) 2 Motion for Summary Judgment (Rule 56) 8 Motion for Summary Judgment (Invalidity) 2

Key Dispositive Motions & Rulings

Motion for Summary Judgment (Rule 56) Pending / Under Review
TEXT ORDER: Upon request from the parties, and for good cause shown, the Court orders that the pending motion for summary judgment [Docket Item 161] shall be re...
Entry #207 • 2018-09-28 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
ORDER administratively terminating Defendants' 161 Motion for Summary Judgment without prejudice, etc. Signed by Judge Jerome B. Simandle on 9/26/2018. (dmr) (E...
Entry #206 • 2018-09-26 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
Minute Entry for proceedings held before Chief Judge Jerome B. Simandle: Motion Hearing held on 10/25/2016 re 161 MOTION for Summary Judgment filed by AMNEAL PH...
Entry #192 • 2016-10-25 Document →
Motion for Summary Judgment (Rule 56) Pending / Under Review
REPLY BRIEF to Opposition to Motion filed by AMNEAL PHARMACEUTICALS INDIA PVT. LTD., AMNEAL PHARMACEUTICALS LLC re 161 MOTION for Summary Judgment (Attachments:...
Entry #186 • 2016-10-14 Document →
Motion for Summary Judgment (Infringement) Pending / Under Review
MEMORANDUM in Opposition filed by OTSUKA PHARMACEUTICAL CO., LTD. re 161 MOTION for Summary Judgment NONINFRINGEMENT (Attachments: # 1 Exhibit 1 and Brief Filed...
Entry #178 • 2016-10-03 Document →
Motion for Summary Judgment (Invalidity) Pending / Under Review
NOTICE by OTSUKA PHARMACEUTICAL CO., LTD. re 164 Notice (Other) NOTICE OF SERVICE OF OPPOSITION TO DEFENDANTS MOTIONS FOR SUMMARY JUDGMENT OF INVALIDITY BY JOIN...
Entry #181 • 2016-10-03 Document →

Docket Entries

(257 total)
Pleading / Complaint

COMPLAINT against AMNEAL PHARMACEUTICALS INDIA PVT. LTD., AMNEAL PHARMACEUTICALS LLC, MSN LABORATORIES PVT. LTD., MSN PHARMACHEM PVT. LTD. ( Filing and Admin fee $ 400 receipt number 0312-6244445), filed by OTSUKA PHARMACEUTICAL CO., LTD.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Civil Cover Sheet, # 6 Certification)(nz, ) (Entered: 03/03/2015)

Entry #1 • 2015-03-02
1

SUMMONS ISSUED as to AMNEAL PHARMACEUTICALS INDIA PVT. LTD., AMNEAL PHARMACEUTICALS LLC, MSN LABORATORIES PVT. LTD., MSN PHARMACHEM PVT. LTD. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. Issued By *Nicholas Zotti* (nz, ) (Entered: 03/03/2015)

Entry #2 • 2015-03-02
1

Corporate Disclosure Statement by OTSUKA PHARMACEUTICAL CO., LTD.. (nz, ) (Entered: 03/03/2015)

Entry #3 • 2015-03-02
1

AO120 Patent/Trademark Form filed. (nz, ) (Entered: 03/03/2015)

Entry #4 • 2015-03-02
1
Court Order

TEXT ORDER The Court hereby CONVERTS the telephone status conference previously set for March 16, 2015 at 3:00 p.m., to an in-person status conference which shall take place in Courtroom 4A - Camden. During the conference, the Court will also address the letter dated March 9, 2015 from Melissa Chuderewicz, Esquire, counsel for plaintiff. Ordered by Magistrate Judge Karen M. Williams on 3/9/2015. (Ramos, Nicole) (Entered: 03/09/2015)

Entry #5 • 2015-03-09
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc